ArcticZymes Technologies — Director's Dealing 2017

May 3, 2017

Biotec Pharmacon - Mandatory notification of trade

Biotec Pharmacon - Mandatory notification of trade

(Tromsø 03. May 2017) Svein Lien, CEO of Biotec Pharmacon has purchased 20.000

shares in Biotec Pharmacon at NOK 6,18 per share via his fully owned company

Spiralen Industrier AS. After this transaction holds Svein Lien and associates

550.829 shares and 160.000 options in Biotec Pharmacon.

This information is subject to the disclosure requirements pursuant to section 5

-12 of the Norwegian Securities Trading Act.

For further information, please contact

Børge Sørvoll

CFO

+47 952 90 187

borge.sorvoll@biotec.no